Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
BillerudKorsnäs | BNF | 26. nov 2024 | 8.40 | -2.55 |
BIMobject | BOJB | 26. nov 2024 | 0.37 | +6.27 |
Binah Capital Group | O1Y | 26. nov 2024 | 2.64 | +9.09 |
Binect AG | MA10 | 26. nov 2024 | 1.81 | 0.00 |
Binhai Investment Co Ltd | WS7A | 26. nov 2024 | 0.11 | -1.74 |
Bio Planet SA | 8WS | 26. nov 2024 | 3.26 | +0.62 |
Bio-Gate AG | BIG1 | 26. nov 2024 | 0.70 | +2.19 |
Bio-Rad Laboratories, Inc. Class A | BUWA | 26. nov 2024 | 317.80 | -0.03 |
Bio-Techne Corp | TE1 | 26. nov 2024 | 71.00 | +4.41 |
Bio-Uv Group | 4Y4 | 26. nov 2024 | 1.58 | -2.22 |
Bio-Works Technologies | 1BD | 26. nov 2024 | 0.05 | -8.18 |
BioArctic B | B9A | 26. nov 2024 | 16.38 | -0.06 |
BioCardia, Inc. | 6JU | 26. nov 2024 | 4.26 | 0.00 |
BIOCELTIX S.A. | XI3 | 26. nov 2024 | 15.34 | +0.66 |
BioCryst Pharmaceuticals, Inc. | BO1 | 26. nov 2024 | 6.89 | -4.86 |
Biocure Technology | 1WH0 | 26. nov 2024 | 0.03 | 0.00 |
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. | I54 | 26. nov 2024 | 0.63 | -24.70 |
Bioera S.P.A | B2A | 26. nov 2024 | 0.03 | +31.30 |
Bioextrax | 85X0 | 26. nov 2024 | 0.29 | -0.69 |
BioFish Holding AS | 9R2 | 26. nov 2024 | 0.04 | -4.12 |
Biofrontera AG | B8FK | 26. nov 2024 | 2.59 | 0.00 |
BIOGAIA AB B O.N. | BGLA | 26. nov 2024 | 9.00 | -1.42 |
Biogen Inc. | IDP | 26. nov 2024 | 151.20 | 0.00 |
BioHarvest Sciences | 8MV0 | 26. nov 2024 | 5.62 | -2.09 |
BioInvent International | BIX0 | 26. nov 2024 | 3.88 | +2.24 |
BioLife Solutions, Inc. | BJX1 | 26. nov 2024 | 25.40 | +1.60 |
BioLineRx Ltd. - American Depositary Shares | YP2A | 26. nov 2024 | 0.19 | -13.89 |
BioMarin Pharmaceutical Inc. | BM8 | 26. nov 2024 | 61.84 | +0.06 |
BioMark Diagnostics Inc | 20B | 26. nov 2024 | 0.12 | +1.72 |
Biomaxima SA | 944 | 26. nov 2024 | 2.72 | -0.73 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.